Cite
MLA Citation
Kevin Cassady et al.. “ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIAL.” Neuro-oncology, vol. 21, n.d., p. vi8. http://access.bl.uk/ark:/81055/vdc_100101669221.0x000041